Subtle Medical Announces Strong 2025 Growth, Expands Market Leadership in AI Imaging
MENLO PARK, Calif., Oct. 1, 2025 /PRNewswire/ — Subtle Medical, a global leader in AI-powered medical imaging, today announced major growth milestones, projecting... Read more.
CORNEX Unveils 588Ah Energy Storage Battery Cell, Targeting Grid-Scale Solutions
XIAOGAN, China, Sept. 30, 2025 /PRNewswire/ — Recently, new energy technology company CORNEX officially launched its next-generation 588Ah large-capacity... Read more.
RapidIdentity: Leading the Charge in Identity Management for Ohio’s Higher Education
HOUSTON, Sept. 30, 2025 /PRNewswire/ — Identity Automation, a Jamf company, is pleased to announce that its industry-leading IAM platform, RapidIdentity,... Read more.
The Perfect Franchise Recognized as No. 4 Franchise Broker in the U.S. by Entrepreneur Magazine
SHOHOLA, Pa., Oct. 1, 2025 /PRNewswire/ — The Perfect Franchise, a leading franchise consulting firm, announced today that it has been ranked No. 4 among Franchise... Read more.
FD Stonewater Acquires New Asset for STAR Evergreen Fund
ARLINGTON, Va., Oct. 1, 2025 /PRNewswire/ — FD Stonewater’s STAR Evergreen Fund, L.P. (the “STAR Fund”) announced the acquisition of Alside... Read more.
IBM and AMD Collaborate with Zyphra on Next Generation AI Infrastructure
Open-source superintelligence company leverages new integrated capabilities for AMD training clusters on IBM Cloud ARMONK, N.Y. and AUSTIN, Texas, Oct. 1, 2025... Read more.
Applitools Names Anand Sundaram Chief Executive Officer
Seasoned software quality and product leader to drive next phase of growth for Applitools’ AI-powered testing platform COVINA, Calif., and TEL AVIV, Israel,... Read more.
Public Launches Fully Customizable Direct Indexing
Public members can now use direct indexing to customize their portfolios, potentially lower tax bills, and gain exposure to specific market segments NEW YORK, Oct.... Read more.
Axcelis Technologies and Veeco Instruments to Combine, Creating a Leading Semiconductor Equipment Company
Diversifies Portfolio with Complementary Capital Equipment Solutions and Expands Addressable Markets Supported by Secular Tailwinds Greater R&D Scale to Fuel... Read more.
Halozyme to Acquire Elektrofi, Expanding Our Offerings in Innovative Drug Delivery and Strengthening Long-Term Growth into 2040s
Royalty revenue contribution expected to begin as early as 2030 Initial partner targets include derisked MoAs that are approved blockbusters today Highly scalable... Read more.